scispace - formally typeset
C

Cheng Liu

Researcher at Scripps Research Institute

Publications -  29
Citations -  2407

Cheng Liu is an academic researcher from Scripps Research Institute. The author has contributed to research in topics: Legumain & Tissue factor. The author has an hindex of 19, co-authored 29 publications receiving 2280 citations.

Papers
More filters
Journal ArticleDOI

Targeting tumor-associated macrophages as a novel strategy against breast cancer

TL;DR: It is demonstrated for the first time that legumain, a member of the asparaginyl endopeptidase family functioning as a stress protein, overexpressed by TAMs, provides an ideal target molecule to suppress tumor growth and metastasis.
Journal ArticleDOI

A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas.

TL;DR: A novel murine gene, hepcarcin (hcn), encoding a 7-kb mRNA-like transcript is identified, the murine ortholog of the human alpha gene, that is, MALAT-1, consistent with a highly conserved large noncoding RNA (ncRNA).
Journal Article

Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy.

TL;DR: A prodrug strategy incorporating a legumain-cleavable peptide substrate onto doxorubicin was developed and the prototype compound exhibited reduced toxicity and was effectively tumoricidal in vivo in a murine colon carcinoma model.
Journal ArticleDOI

Targeting Cell-Impermeable Prodrug Activation to Tumor Microenvironment Eradicates Multiple Drug-Resistant Neoplasms

TL;DR: It is shown that legumain, the only asparaginyl endopeptidase of the mammalian genome, is highly expressed by neoplastic, stromal, and endothelial cells in solid tumors and thus provides new potentials for the rational development of more effective functionally targeted cancer therapeutics.
Journal Article

Prostate-specific Membrane Antigen Directed Selective Thrombotic Infarction of Tumors

TL;DR: It is found that the channel structures delineated by PSMA-expressing cells in human and rat prostate tumors are in functional continuity with the vasculature and thus form part of tumor microvasculature, which expands the therapeutic potential for selective infarctive ablation of tumors.